ERBB2 and breast carcinoma: A competition assay showed that the His6-G3 labelled with cold indium and cold iodine, (HE)3-G3 and untagged G3 all competed with [99mTc(CO)3]+-G3 DARPin-His6 for binding to HER2-positive human breast cancer cells (BT474).